Determinants of piperaquine-resistant malaria in South America

Lancet Infect Dis. 2024 Feb;24(2):114-116. doi: 10.1016/S1473-3099(23)00564-9. Epub 2023 Oct 16.
No abstract available

MeSH terms

  • Antimalarials* / therapeutic use
  • Humans
  • Malaria* / drug therapy
  • Malaria* / epidemiology
  • Malaria* / prevention & control
  • Malaria, Falciparum* / drug therapy
  • Malaria, Falciparum* / epidemiology
  • Malaria, Falciparum* / prevention & control
  • Piperazines*
  • Quinolines* / therapeutic use
  • South America / epidemiology

Substances

  • piperaquine
  • Quinolines
  • Antimalarials
  • Piperazines